Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Diagnosis of bacterial overgrowth after culturing proximal small-bowel aspirate obtained during routine upper gastrointestinal endoscopy.

Bardhan PK, Gyr K, Beglinger C, Vögtlin J, Frey R, Vischer W.

Scand J Gastroenterol. 1992;27(3):253-6.

PMID:
1502491
2.

Helicobacter pylori infection in healthy people: a dynamic process?

Meyer B, Werth B, Beglinger C, Dill S, Drewe J, Vischer WA, Eggers RH, Bauer FE, Stalder GA.

Gut. 1991 Apr;32(4):347-50.

3.

[Campylobacter pylori, gastritis and ulcer disease. Microbiological, histological and serological studies].

Schaub N, Stalder H, Stalder GA, Marbet UA, Vögtlin J, Affolter H, Wegmann W, Vischer WA, Zingel O, Tanner K, et al.

Schweiz Med Wochenschr. 1988 Mar 5;118(9):293-301. Review. German.

PMID:
3282302
4.

CGP 4832, a new semisynthetic rifamycin derivative highly active against some gram-negative bacteria.

Wehrli W, Zimmermann W, Kump W, Tosch W, Vischer W, Zak O.

J Antibiot (Tokyo). 1987 Dec;40(12):1733-9.

5.

Pharmacokinetics of clofazimine in healthy volunteers.

Schaad-Lanyi Z, Dieterle W, Dubois JP, Theobald W, Vischer W.

Int J Lepr Other Mycobact Dis. 1987 Mar;55(1):9-15.

PMID:
3559339
6.

Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8.

Hochkeppel HK, Braun DG, Vischer W, Imm A, Sutter S, Staeubli U, Guggenheim R, Kaplan EL, Boutonnier A, Fournier JM.

J Clin Microbiol. 1987 Mar;25(3):526-30.

7.

[Failure of doxycycline in Campylobacter pylori-positive gastritis].

Schaub N, Stalder H, Vischer W, Stalder GA, Affolter H, Wegmann W.

Dtsch Med Wochenschr. 1987 Jan 16;112(3):117-8. German. No abstract available.

PMID:
3803221
8.

Symmetrical peripheral gangrene in disseminated tuberculosis.

Itin P, Stalder H, Vischer W.

Dermatologica. 1986;173(4):189-95.

PMID:
3770263
9.

[Determination of the sensitivity of microorganisms to antimicrobial agents; standardization of the antibiogram].

von Graevenitz A, Heitz M, Lüthy R, Meyer J, Vischer W.

Schweiz Rundsch Med Prax. 1985 Oct 15;74(42):1134-40. French. No abstract available.

PMID:
4070900
10.

[Frequency of toxic-shock-syndrome-toxin producing strains of Staphylococcus aureus in the Basel region].

Vischer WA, Stalder H, Faupel DM.

Schweiz Med Wochenschr. 1985 Aug 31;115(35):1196-9. German.

PMID:
4048915
11.

Etiology of acute infectious diarrhea in a highly industrialized area of Switzerland.

Loosli J, Gyr K, Stalder H, Stalder GA, Vischer W, Voegtlin J, Gasser M, Reichlin B.

Gastroenterology. 1985 Jan;88(1 Pt 1):75-9.

PMID:
3964774
12.

[Standardized disk tests for the determination of bacterial resistance ].

von Graevenitz A, Heitz M, Lüthy R, Meyer J, Vischer W.

Schweiz Med Wochenschr. 1984 Aug 7;114(31-32):1079-86. German.

PMID:
6436967
13.

Modified guaiac test may replace search for faecal leukocytes in acute infectious diarrhea.

Vögtlin J, Stalder H, Hürzeler L, Vischer W, Loosli J, Gyr K, Stalder GA.

Lancet. 1983 Nov 19;2(8360):1204. No abstract available.

PMID:
6139563
14.

[Contribution to the epidemiology of Campylobacter jejuni. From asymptomatic excretion by a cow in the cowshed to overt disease in over 500 persons].

Stalder H, Isler R, Stutz W, Salfinger M, Lauwers S, Vischer W.

Schweiz Med Wochenschr. 1983 Feb 19;113(7):245-9. German.

PMID:
6836250
15.

[Dosage of cephacetrile in blood and CSF in ten purulent meningitis ].

Gallais H, Raoult D, Kohler JL, Vischer WA, Casanova P.

Pathol Biol (Paris). 1982 Jun;30(6 Pt 2):526-8. French. No abstract available.

PMID:
6750520
16.

[Multicenter study on the status of antibiotic and chemotherapy resistance in Switzerland 1979].

Vischer WA, Piguet JD, Pitton JS, Lüthy R, Nicolet J.

Schweiz Med Wochenschr. 1982 Mar 20;112(12):404-10. German.

PMID:
7071561
17.

Pharmacokinetic comparison of cefroxadin (CGP 9000) and cephalexin by simultaneous administration to humans.

Lecaillon JB, Hirtz JL, Schoeller JP, Humbert G, Vischer W.

Antimicrob Agents Chemother. 1980 Nov;18(5):656-60.

18.

Lamprene (clofazimine) in leprosy. Basic information.

Yawalkar SJ, Vischer W.

Lepr Rev. 1979 Jun;50(2):135-44. Review. No abstract available.

PMID:
396428
19.
20.

Antibiotic sensitivity of gonococcal strains isolated from patients in Basel and environs.

Füllhaas J, Vischer WA, Brügger P, Rufli T.

Dermatologica. 1979;158(4):249-56.

PMID:
155016
21.

Rifampicin against experimental listeriosis in the mouse.

Vischer WA, Rominger C.

Chemotherapy. 1978;24(2):104-11.

PMID:
413697
22.

[Simple method for preservation of bacteria in small portions (author's transl)].

Vischer WA, Solf R.

Zentralbl Bakteriol Orig A. 1976 Dec;236(4):565-7. German.

PMID:
797183
23.

CGP 9000: a new orally active, broad-spectrum cephalosporin.

Zak O, Vischer WA, Schenk C, Tosch W, Zimmermann W, Regös J, Suter ER, Kradolfer F, Gelzer J.

J Antibiot (Tokyo). 1976 Jun;29(6):653-5.

24.

[Experimental evaluation of the new cephalosporin antibiotic cephacetrile].

Kradolfer F, Ahrens T, Gelzer J, Vischer W, Zimmermann W.

Arzneimittelforschung. 1974 Sep;24(9b):1446-51. German. No abstract available.

PMID:
4154769
25.

Antimicrobial spectrum of Triclosan, a broad-spectrum antimicrobial agent for topical application.

Vischer WA, Regös J.

Zentralbl Bakteriol Orig A. 1974 Mar;226(3):376-89. No abstract available.

PMID:
4151802
26.

[Experimental trials with the new cephalosporin antibiotic celospor (Cephacetril)].

Kradolfer F, Ahrens T, Gelzer J, Vischer W, Zimmermann W.

Schweiz Med Wochenschr. 1973 May 12;103(19):711-8. German. No abstract available.

PMID:
4703915
27.

[Comparative study on the effect of some clinically used sulfanilamide derivatives against toxoplasmosis in the mouse].

Vischer WA.

Zentralbl Bakteriol Orig A. 1973 Mar;223(2):398-408. German. No abstract available.

PMID:
4145848
28.

[A selective medium with hexamethyl phosphoric acid triamide for isolation of atypical mycobacteria].

Vischer WA.

Zentralbl Bakteriol Orig A. 1972 Jun;220(4):550-3. German. No abstract available.

PMID:
4144935
29.

Rapid quantitative evaluation of chemotherapeutic agents in experimental cystitis of rats.

Vischer WA.

Chemotherapy. 1972;17(4):293-304. No abstract available.

PMID:
4625197
30.

Prophylactic effect of clofazimine in murine tuberculosis.

Vischer WA.

Zentralbl Bakteriol Orig A. 1971 Sep;218(1):68-74. No abstract available.

PMID:
4400128
31.
32.

Antituberculosis activity of some nitrofuran derivatives.

Bruhin H, Bühlmann X, Hook WH, Hoyle W, Orford B, Vischer W.

J Pharm Pharmacol. 1969 Jul;21(7):423-33. No abstract available.

PMID:
4390065
33.

The experimental properties of G 30 320 (B 663)--a new anti-leprotic agent.

Vischer WA.

Lepr Rev. 1969 Apr;40(2):107-10. No abstract available.

PMID:
5792376
34.
35.

[Possibilities and limitations of ethylene oxide sterilization].

Bruhin H, Bühlmann X, Vischer WA.

Zentralbl Bakteriol Orig. 1968;208(4):563-7. German. No abstract available.

PMID:
5000092
36.

[. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy].

Vischer WA.

Schweiz Med Wochenschr. 1967 Mar 11;97(10):308. German. No abstract available.

PMID:
5585384
37.

[POSSIBILITIES OF STERILIZATION OF BIOLOGICAL CULTURE-MEDIA INGREDIENTS WITH BETA-PROPIOLACTONE].

VISCHER WA, BUEHLMANN X, BRUHIN H.

Pathol Microbiol (Basel). 1963;26:515-23. German. No abstract available.

PMID:
14114125
38.

[Combined chemotherapy in mouse tuberculosis. Synergistic effect of phenothiazine derivatives with isoniazid. Evaluation with the bacterial count method].

VISCHER WA, ROULET FC.

Beitr Klin Tuberk Spezif Tuberkuloseforsch. 1963;126:253-70. German. No abstract available.

PMID:
13997476
39.

Streptomycin and amino acid metabolism of bacteria.

TIRUNARAYANAN MO, VISCHER WA, RENNER U.

Antibiot Chemother (Northfield). 1962 Feb;12:117-22. No abstract available.

PMID:
13921360
40.

Identification of apyocyanogenic strains of Pseudomonas aeruginosa.

BUHLMANN X, VISCHER WA, BRUHIN H.

J Bacteriol. 1961 Nov;82:787-8. No abstract available.

41.

[A simple method for isolation of anaerobes in bacteriological diagnosis].

ROTH W, VISCHER WA.

Pathol Microbiol (Basel). 1961;24:752-5. German. No abstract available.

PMID:
14494409
42.

[Current methods for differentiation of human and bovine tubercle bacteria].

VISCHER WA.

Pathol Microbiol (Basel). 1961;24:741-51. German. No abstract available.

PMID:
13926209
43.

Some properties of catechol peroxidase of mycobacteria bearing on isoniazid susceptibility.

TIRUNARAYANAN MO, VISCHER WA, BRUHIN H.

J Bacteriol. 1960 Oct;80:423-9. No abstract available.

44.

Amithiozone: mechanism of action and resistance development by mycobacteria.

TIRUNARAYANAN MO, VISCHER WA, BRUHIN H.

Am Rev Respir Dis. 1959 Oct;80:559-68. No abstract available.

PMID:
13838487
45.

Inactivation of isoniazid by peroxidase.

TIRUNARAYANAN MO, VISCHER WA.

Nature. 1959 Mar 7;183(4662):681. No abstract available.

PMID:
13632829
46.

[New chemical methods for rapid differentiation of isoniazid-sensitive and isoniazid-resistant tubercle bacilli].

VISCHER WA, TIRUNARAYANAN MO, BRUHIN H.

Schweiz Z Pathol Bakteriol. 1959;22:577-88. German. No abstract available.

PMID:
13842455
47.

[Demonstration of sporadic isoniazid-sensitive colonies in a primarily isoniazid-resistant culture with the aid of peroxidase tests].

VISCHER WA, TIRUNARAYANAN MO, BRUHIN H.

Schweiz Z Tuberc Pneumonol. 1959;16:415-8. German. No abstract available.

PMID:
13842454
48.

[Studies on the mechanism of action of thiosemicarbazone].

TIRUNARAYANAN MO, VISCHER WA, BRUHIN H.

Schweiz Z Pathol Bakteriol. 1958;21(5):964-9. German. No abstract available.

PMID:
13602762
49.

[A phenazine derivative with strong tuberculostatic effect; bacteriological & experimental animal studies].

VISCHER WA, TIRUNARAYANAN MO, BRUHIN H.

Beitr Klin Tuberk Spezif Tuberkuloseforsch. 1958;119(1):59-66. German. No abstract available.

PMID:
13596302
50.

[The significance of peroxidase activity in Mycobacteria].

VISCHER WA, TIRUNARAYANAN MO.

Schweiz Z Tuberc Pneumonol. 1957;14(4):243-6. German. No abstract available.

PMID:
13495420

Supplemental Content

Loading ...
Support Center